Senate Health Committee Chairman Lamar Alexander (R-Tenn.) said Wednesday that drug pricing measures could be considered as part of the medical innovation bill that his committee is working on.
He said he expects that there will be a proposal from Sens. Claire McCaskill (D-Mo.) and Susan Collins (R-Maine), who have been investigating spikes in drug prices in the Senate Aging Committee.
Read Full Article »